Providing a revolutionary recombinant protein expression platform
T3S Technologies leverages its expertise in genetics, biochemistry, and proprietary technologies to enable the expression and optimization of any difficult-to-express recombinant protein product.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2016 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |